This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Yuan, J.-M. Articles by Yu, M. C. Search for Related Content PubMed PubMed Citation Articles by Yuan, J.-M. Articles by Yu, M. C.

Prediagnostic Levels of Serum ß-Cryptoxanthin and Retinol Predict Smoking-related Lung Cancer Risk in Shanghai, China¹

Department of Preventive Medicine, University of Southern California/Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, California 90033 [J-M. Y., R. K. R., M. C. Y.], and Department of Epidemiology, Shanghai Cancer Institute, Shanghai 200032, People’s Republic of China [X-D. C., Y-T. G.]

Higher blood levels of ß-carotene have been found to be associated with reduced risk of lung cancer, but large intervention trials have failed to demonstrate reduced lung cancer incidence after prolonged high-dose ß-carotene supplementation. Data on blood levels of specific carotenoids other than ß-carotene in relation to lung cancer are scarce. Little is known about the relationship between prediagnostic serum levels of carotenoids, retinol, and tocopherols, and risk of lung cancer especially in non-Western populations. Between January 1986 and September 1989, 18,244 men ages 45–64 years participated in a prospective study of diet and cancer in Shanghai, China. Information on tobacco smoking and other lifestyle factors was obtained through in-person interviews. A serum sample was collected from each study participant at baseline. During the first 12 years of follow-up, 209 lung cancer cases, excluding those diagnosed within 2 years of enrollment, were identified. For each cancer case, three cancer-free control subjects were randomly selected from the cohort and matched to the index case by age (within 2 years), month and year of blood sample collection, and neighborhood of residence. Serum concentrations of retinol, - and -tocopherols, and specific carotenoids including -carotene, ß-carotene, ß-cryptoxanthin, lycopene, and lutein/zeaxanthin were determined on the 209 cases and 622 matched controls by high-performance liquid chromatography methods. A high prediagnostic serum level of ß-cryptoxanthin was significantly associated with reduced risk of lung cancer; relative to the lowest quartile, the smoking-adjusted relative risks (95% confidence intervals) for the 2nd, 3rd, and 4th quartile categories were 0.72 (0.41–1.26), 0.42 (0.21–0.84), and 0.45 (0.22–0.92), respectively (P for trend = 0.02). Increased serum levels of other specific carotenoids including -carotene, ß-carotene, lycopene, and lutein/zeaxanthin were related to reduced risk of lung cancer although the inverse associations were no longer statistically significant after adjustment for smoking. A statistically significant 37% reduction in risk of lung cancer was noted in smokers with above versus below median level of total carotenoids. Serum retinol levels showed a threshold effect on lung cancer risk. Compared with the lowest quartile (<40 µg/dl), the smoking-adjusted relative risk (95% confidence interval) was 0.60 (0.39–0.92) for men in the 2nd-4th quartiles of retinol values combined; no additional decrease in risk was observed between individuals from the 2nd to 4th quartiles. There were no associations between prediagnostic serum levels of - and -tocopherols and lung cancer (all Ps for trend 0.4). The present data indicate that higher prediagnostic serum levels of total carotenoids and ß-cryptoxanthin were associated with lower smoking-related lung cancer risk in middle-aged and older men in Shanghai, China. Low level of serum retinol (with a threshold effect) is associated with increased lung cancer risk in this oriental population.

This article has been cited by other articles:

				J.-M. Yuan, W.-P. Koh, S. E. Murphy, Y. Fan, R. Wang, S. G. Carmella, S. Han, K. Wickham, Y.-T. Gao, M. C. Yu, et al. Urinary Levels of Tobacco-Specific Nitrosamine Metabolites in Relation to Lung Cancer Development in Two Prospective Cohorts of Cigarette Smokers Cancer Res., April 1, 2009; 69(7): 2990 - 2995. [Abstract] [Full Text] [PDF]

				L. Gallicchio, K. Boyd, G. Matanoski, X. Tao, L. Chen, T. K Lam, M. Shiels, E. Hammond, K. A Robinson, L. E Caulfield, et al. Carotenoids and the risk of developing lung cancer: a systematic review Am. J. Clinical Nutrition, August 1, 2008; 88(2): 372 - 383. [Abstract] [Full Text] [PDF]

				A. J. Alberg, J. G. Ford, and J. M. Samet Epidemiology of Lung Cancer: ACCP Evidence-Based Clinical Practice Guidelines (2nd Edition) Chest, September 1, 2007; 132(3_suppl): 29S - 55S. [Abstract] [Full Text] [PDF]

				C. J. Kavanaugh, P. R. Trumbo, and K. C. Ellwood The U.S. Food and Drug Administration's Evidence-Based Review for Qualified Health Claims: Tomatoes, Lycopene, and Cancer J Natl Cancer Inst, July 18, 2007; 99(14): 1074 - 1085. [Abstract] [Full Text] [PDF]

				J. D. Ribaya-Mercado and J. B. Blumberg Lutein and Zeaxanthin and Their Potential Roles in Disease Prevention J. Am. Coll. Nutr., December 1, 2004; 23(suppl_6): 567S - 587S. [Abstract] [Full Text] [PDF]

				J.-M. Yuan, R. K. Ross, Y.-T. Gao, Y.-H. Qu, X.-D. Chu, and M. C. Yu Prediagnostic Levels of Serum Micronutrients in Relation to Risk of Gastric Cancer in Shanghai, China Cancer Epidemiol. Biomarkers Prev., November 1, 2004; 13(11): 1772 - 1780. [Abstract] [Full Text] [PDF]

				Correspondence re Yuan JM et al., Prediagnostic Levels of Serum {beta}-Cryptoxanthin and Retinol Predict Smoking-Related Lung Cancer Risk in Shanghai, China. 2001;10:767-73. Neuhoser ML et al., Fruits and Vegetables Are Associated with Lower Lung Cancer Risk Only in the Placebo Arm of the {beta}-Carotene and Retinol Efficacy Trial (CARET). 2002;12:350-8. Satia-Abouta J et al., Associations of Micronutrients with Colon Cancer Risk in African Americans and Whites: Results from the North Carolina Colon Cancer Study. 2003;12:747-54. Cancer Epidemiol. Biomarkers Prev., April 1, 2004; 13(4): 679 - 680. [Full Text] [PDF]

				S. Mannisto, S. A. Smith-Warner, D. Spiegelman, D. Albanes, K. Anderson, P. A. van den Brandt, J. R. Cerhan, G. Colditz, D. Feskanich, J. L. Freudenheim, et al. Dietary Carotenoids and Risk of Lung Cancer in a Pooled Analysis of Seven Cohort Studies Cancer Epidemiol. Biomarkers Prev., January 1, 2004; 13(1): 40 - 48. [Abstract] [Full Text] [PDF]

				B.-L. Lee, A.-L. New, and C.-N. Ong Simultaneous Determination of Tocotrienols, Tocopherols, Retinol, and Major Carotenoids in Human Plasma Clin. Chem., December 1, 2003; 49(12): 2056 - 2066. [Abstract] [Full Text] [PDF]

				J.-M. Yuan, D. O. Stram, K. Arakawa, H.-P. Lee, and M. C. Yu Dietary Cryptoxanthin and Reduced Risk of Lung Cancer: The Singapore Chinese Health Study Cancer Epidemiol. Biomarkers Prev., September 1, 2003; 12(9): 890 - 898. [Abstract] [Full Text] [PDF]

				G. E. Goodman, S. Schaffer, G. S. Omenn, C. Chen, and I. King The Association between Lung and Prostate Cancer Risk, and Serum Micronutrients: Results and Lessons Learned from {beta}-Carotene and Retinol Efficacy Trial Cancer Epidemiol. Biomarkers Prev., June 1, 2003; 12(6): 518 - 526. [Abstract] [Full Text] [PDF]

				M. L. Neuhouser, R. E. Patterson, M. D. Thornquist, G. S. Omenn, I. B. King, and G. E. Goodman Fruits and Vegetables Are Associated with Lower Lung Cancer Risk Only in the Placebo Arm of the {beta}-Carotene and Retinol Efficacy Trial (CARET) Cancer Epidemiol. Biomarkers Prev., April 1, 2003; 12(4): 350 - 358. [Abstract] [Full Text] [PDF]